Shares in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) climbed nearly 2% in after-hours trading Monday after the U.S.
Maxim’s Jason McCarthy believes Vertex could “unlock” over 90% of the cystic fibrosis market as time passes.
Drug maker Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) reported a beat and raise this quarter both on the top and bottom-line for Q3 2017. During …
